Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Ustav Organicke Chemie A Biochemie Av Cr V V I is active in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action. This single action is being reviewed by 1 distinct examiner within 1 distinct art unit. This distribution indicates a concentrated prosecution environment for the company's current biotechnology filings.
The busiest examiner identified in the data is POHNERT, STEVEN C. This examiner is responsible for 1 pending office action. Because the total number of pending actions is 1, this examiner manages the entire active portfolio. This singular focus means that the prosecution strategy is currently centered on the interpretations and requirements of this specific individual.
The presence of 1 distinct art unit suggests that the subject matter of the pending application is specialized. There are no other examiners or art units involved to provide a comparative baseline for the company's prosecution efforts. This results in a streamlined set of proceedings within the Biotechnology & Pharmaceuticals field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POHNERT, STEVEN C | 1 | 12.5% | +18.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275046 | Deoxyribozymes Generating Chemiluminescent Signals | POHNERT, STEVEN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275046 | Deoxyribozymes Generating Chemiluminescent Signals | POHNERT, STEVEN C | — |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18275046 | Deoxyribozymes Generating Chemiluminescent Signals | POHNERT, STEVEN C | 1683 | §102§112 | Non-Final OA | — | Pending | Jul 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUstav Organicke Chemie A Biochemie Av Cr V V I has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Steven C Pohnert has the most, with 1 of Ustav Organicke Chemie A Biochemie Av Cr V V I's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
